Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 9 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Mitsiades, Constantine S [Clear All Filters]
Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomib..
Clin Cancer Res. 15(23), 7153-60.
(2009). Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications..
Invest Ophthalmol Vis Sci. 50(9), 4072-9.
(2009). Mutational analysis of the BRAF, RAS and EGFR genes in human adrenocortical carcinomas..
Endocr Relat Cancer. 16(2), 565-72.
(2009). Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition..
J Clin Endocrinol Metab. 92(12), 4845-52.
(2007). The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro..
Invest Ophthalmol Vis Sci. 48(10), 4706-19.
(2007). Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro..
J Clin Endocrinol Metab. 91(10), 4013-21.
(2006). Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis..
J Clin Endocrinol Metab. 91(9), 3662-6.
(2006). Regulation of vascular endothelial growth factor expression by insulin-like growth factor I in thyroid carcinomas..
J Clin Endocrinol Metab. 88(11), 5392-8.
(2003).
(2002).